Skip Navigation


JAC Advance Access originally published online on September 10, 2009
Journal of Antimicrobial Chemotherapy 2009 64(5):986-989; doi:10.1093/jac/dkp336
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow All Versions of this Article:
64/5/986    most recent
dkp336v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Oxacelay, C.
Right arrow Articles by Nordmann, P.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Oxacelay, C.
Right arrow Articles by Nordmann, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

Original research

Rapid detection of CTX-M-producing Enterobacteriaceae in urine samples

Cynthia Oxacelay{dagger}, Ayla Ergani{dagger}, Thierry Naas* and Patrice Nordmann

Service de Bactériologie-Virologie, INSERM U914: ‘Emerging Resistance to Antibiotics’, Hôpital de Bicêtre, Assistance Publique-Hôpitaux de Paris, Faculté de Médecine, Université Paris-Sud, 94275 Le Kremlin-Bicêtre, France

Received 24 June 2009; returned 27 July 2009; revised 18 August 2009; accepted 19 August 2009


* Corresponding author. Tel: +33-1-45-21-29-86; Fax: +33-1-45-21-63-40; E-mail: thierry.naas{at}bct.ap-hop-paris.fr

Objectives: CTX-M extended-spectrum β-lactamases (ESBLs) are emerging worldwide. Fast and reliable detection techniques may become mandatory for implementing proper treatment and infection control measures. Here, a blaCTX-M-specific LightCycler real-time PCR (LC-PCR) assay based on hybridization probes was developed.

Methods: Urine samples positive for Gram-negative bacilli as revealed by Gram staining were collected over a 3 month period at Bicêtre hospital, France. Aliquots of these urine samples were frozen for subsequent molecular analysis, and the bacteria were cultured and identified by standard bacteriological techniques (biochemical tests, disc diffusion antibiogram and synergy testing). LC-PCR and standard PCR followed by sequencing was performed on all ESBL-positive and on 70 randomly chosen ESBL-negative urine samples.

Results: Over the study period, 810 urine samples were collected from 655 patients. Thirty-six ESBL-producing Enterobacteriaceae, mostly Escherichia coli (77%), were identified from 29 patients, of which half were outpatients. Twenty-five urine samples (19 patients) were found to be positive for blaCTX-M genes using the LC-PCR assay. The blaCTX-M genes belonged to the blaCTX-M-1, blaCTX-M-9 and blaCTX-M-2 groups (68%, 24% and 8%, respectively). Standard PCR and sequencing of the entire blaCTX-M genes confirmed the LC-PCR results; 17 CTX-M-15, 6 CTX-M-9 and 2 CTX-M-2. Among the remaining ESBLs, eight were of the TEM type and three of the SHV type.

Conclusions: The LC-PCR assay represents a powerful tool for rapid identification of CTX-M producers in urine samples.

Keywords: ESBLs , detection , real-time PCR , hybridization probes


{dagger} C. O. and A. E. contributed equally to this work.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.